Riskpilot← Back to searchSign inGet full accessRADFARMA AS
ASActiveOrg 922675562Ullernchausséen 64, 0379 OsloEconomic activity was not specified by tax authority · NACE 0000Est. 20190 employees
Revenue 2023
NOK 0
EBITDA margin
—
-54% vs 2022
Equity ratio
-641.0%
Financial strength
Net profit 2023
NOK -111K
-57% vs 2022
| Revenue | NOK 0 | — |
| EBITDA | NOK -105K | -54% |
| Net profit | NOK -111K | -57% |
| Total assets | NOK 238K | -10% |
| Equity | NOK -1,5M | -8% |
| Employees | 0 | — |
Legal name
RADFARMA AS
Org number
922675562
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
4. juni 2019
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Company purpose
Eie og delta i selskap innen legemiddelindustrien og dertil tilhørende virksomhet.
Address
Ullernchausséen 64, 0379 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 306 | 1 044 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −963 | −391 | −87 | −68 | −105 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −963 | −391 | −87 | −68 | −105 |
| Net financials | 0 | −1 | −1 | −3 | −7 |
| Profit before tax | −963 | −392 | −88 | −71 | −111 |
| Tax | −212 | 212 | −0 | −0 | −0 |
| Net profit | −751 | −604 | −88 | −71 | −111 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 311 | 1 447 | 413 | 265 | 238 |
| Equity | −651 | −1 255 | −1 343 | −1 414 | −1 525 |
| Long-term debt | 150 | 869 | 0 | 0 | 0 |
| Short-term debt | 813 | 1 834 | 1 756 | 1 679 | 1 763 |
| Total debt | 963 | 2 703 | 1 756 | 1 679 | 1 763 |
EBITDA margin
-10458700.0%
This company
15.8%
Market median
-66194404% vs market
20192023
Equity ratio
-641.0%
This company
38.2%
Market median
-1778% vs market
20192023
Return on equity
-11117400.0%
This company
18.4%
Market median
-60420752% vs market
20192023
Net profit margin
-11117400.0%
This company
8.1%
Market median
-137251952% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
1.16×
This company
0.62×
Market median
-87% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Deputy Chairman | 2019 | |
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 45% | 45% | 2022 | |
| Company | 45% | 45% | 2022 | |
| Company | 10% | 10% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bjr International As
RADFARMA AS Board members of RADFARMA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hendrik Johannes Strydom | Deputy Chairman | 0 companies |
| Thor Audun Saga | Chairman | 0 companies |
| Vivi Høgstedt Strehl | Board of Directors | 0 companies |
| William James Patrick Woodcock | Board of Directors | 0 companies |
| Bjørg Røde | Board of Directors | 0 companies |
| Einar Ronander | Board of Directors | 0 companies |